Page 582 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

560 PART IV Specific Malignancies in the Small Animal Patient

223. Pooya HA, Seguin B, Mason DR, et al.: Biomechanical comparison 242. Culp WT, Olea-Popelka F, Sefton J, et al.: Evaluation of outcome
of cortical radial graft versus ulnar transposition graft limb-sparing and prognostic factors for dogs living greater than one year after
techniques for the distal radial site in dogs, Vet Surg 33:301–308, diagnosis of osteosarcoma; 90 cases (1997-2008), J Am Vet Med
VetBooks.ir 224. Seguin B, Walsh PJ, Mason DR, et al.: Use of an ipsilateral vas- 243. Jeys LM, Grimer RJ, Carter SR, et al.: Post operative infection and
Assoc 245:1141–1146, 2014.
2004.
cularized ulnar transposition autograft for limb-sparing surgery of
the distal radius in dogs; an anatomic and clinical study, Vet Surg increased survival in osteosarcoma patients; are they associated?
Ann Surg Oncol 14:2887–2895, 2007.
32:69–79, 2003. 244. Sottnik JL, U’Ren LW, Thamm DH, et al.: Chronic bacterial
225. Liptak JM, Dernell WS, Lascelles BD, et al.: Intraoperative extra- osteomyelitis suppression of tumor growth requires innate immune
corporeal irradiation for limb sparing in 13 dogs, Vet Surg 33:446– responses, Cancer Immunol Immunother 59:367–378, 2010.
456, 2004. 245. Kramer A, Walsh PJ, Seguin B: Hemipelvectomy in dogs and cats;
226. Boston SE, Duerr F, Bacon N, et al.: Intraoperative radiation for technique overview, variations, and description, Vet Surg 37:413–
limb sparing of the distal aspect of the radius without transcarpal 419, 2008.
plating in five dogs, Vet Surg 36:314–323, 2007. 246. Straw RC, Withrow SJ, Powers BE: Partial or total hemipelvectomy
227. Oya N, Kokubo M, Mizowaki T, et al.: Definitive intraopera- in the management of sarcomas in nine dogs and two cats, Vet Surg
tive very high-dose radiotherapy for localized osteosarcoma in the 21:183–188, 1992.
extremities, Int J Radiat Oncol 51:87–93, 2001. 247. Bray JP: Hemipelvectomy; modified surgical technique and clinical
228. Sakayama K, Kidani T, Fujibuchi T, et al.: Definitive intraop- experiences from a retrospective study, Vet Surg 43:19–26, 2014.
erative radiotherapy for musculoskeletal sarcomas and malignant 248. Chauvet AE, Hogge GS, Sandin JA, et al.: Vertebrectomy, bone
lymphoma in combination with surgical excision, Int J Clin Oncol allograft fusion, and antitumor vaccination for the treatment of
8:174–179, 2003. vertebral fibrosarcoma in a dog, Vet Surg 28:480–488, 1999.
229. Tsuboyama T, Toguchida J, Kotoura Y, et al.: Intra-operative 249. Nakata K, Miura H, Sakai H, et al.: Vertebral replacement for the
radiation therapy for osteosarcoma in the extremities, Int Orthop treatment of vertebral osteosarcoma in a cat, J Vet Med Sci 79:999–
24:202–207, 2000. 1002, 2017.
230. Farese JP, Milner R, Thompson MS, et al.: Stereotactic radiosur- 250. Liptak JM, Dernell WS, Rizzo SA, et al.: Partial foot amputation in
gery for treatment of osteosarcomas involving the distal portions of 11 dogs, J Am Anim Hosp Assoc 41:47–55, 2005.
the limbs in dogs, J Am Vet Med Assoc 225:1567–1572, 2004. 251. Fitzpatrick N, Smith TJ, Pendegrass CJ, et al.: Intraosseous trans-
231. Kubicek L, Vanderhart D, Wirth K, et al.: Association between cutaneous amputation prosthesis (ITAP) for limb salvage in 4 dogs,
computed tomographic characteristics and fractures following ste- Vet Surg 40:909–925, 2011.
reotactic radiosurgery in dogs with appendicular osteosarcoma, Vet 252. Drygas KA, Taylor R, Sidebotham CG, et al.: Transcutaneous tibial
Radiol Ultrasound 57:321–330, 2016. implants; a surgical procedure for restoring ambulation after ampu-
232. Curtis RC, Custis JT, Ehrhart NP, et al.: Combination therapy tation of the distal aspect of the tibia in a dog, Vet Surg 37:322–
with zoledronic acid and parathyroid hormone improves bone 327, 2008.
architecture and strength following a clinically-relevant dose of ste- 253. Kirpensteijn J, Straw RC, Pardo AD, et al.: Partial and total scapu-
reotactic radiation therapy for the local treatment of canine osteo- lectomy in the dog, J Am Anim Hosp Assoc 30:313–319, 1994.
sarcoma in athymic rats, PLoS One 11:e0158005, 2016. 254. Montinaro V, Boston SE, Buracco P, et al.: Clinical outcome of 42
233. Powers BE, Withrow SJ, Thrall DE, et al.: Percent tumor necrosis dogs with scapular tumors treated by scapulectomy; a Veterinary
as a predictor of treatment response in canine osteosarcoma, Cancer Society of Surgical Oncology (VSSO) retrospective study (1995–
67:126–134, 1991. 2010), Vet Surg 42:943–950, 2013.
234. Pagano C, Boudreaux B, Shiomitsu K: Safety and toxicity of an 255. Straw RC, Withrow SJ, Powers BE: Primary osteosarcoma of the
accelerated coarsely fractionated radiation protocol for treatment ulna in 12 dogs, J Am Anim Hosp Assoc 27:323–326, 1991.
of appendicular osteosarcoma in 14 dogs;10 Gy x 2 fractions, Vet 256. Duncan B, Lascelles X, Thomson MJ, et al.: Combined dorsolateral
Radiol Ultrasound 57:551–556, 2016. and intraoral approach for the resection of tumors of the maxilla in
235. Van Ginkel RJ, Hoekstra HJ, Meutstege FJ, et al.: Hyperthermic the dog, J Am Anim Hosp Assoc 39:294–305, 2003.
isolated regional perfusion with cisplatin in the local treatment 257. Fox LE, Geoghegan SL, Davis LH, et al.: Owner satisfaction with
of spontaneous canine osteosarcoma; assessment of short-term partial mandibulectomy or maxillectomy for treatment of oral
effects, J Surg Oncol 59:169–176, 1995. tumors in 27 dogs, J Am Anim Hosp Assoc 33:25–31, 1997.
236. Rossi CR, Pasquali S, Mocellin S, et al.: Long-term results of 258. White RAS: Mandibulectomy and maxillectomy in the dog - long-
melphalan-based isolated limb perfusion with or without low-dose term survival in 100 cases, J Sm Anim Pract 32:69–74, 1991.
tnf for in-transit melanoma metastases, Ann Surg Oncol 17:3000– 259. Withrow SJ, Holmberg DL: Mandibulectomy in the treatment of
3007, 2010. oral cancer, J Am Anim Hosp Assoc 19:273–286, 1983.
237. Deroose JP, Van Geel AN, Burger JWA, et al.: Isolated limb perfu- 260. OBrien MG, Withrow SJ, Straw RC, et al.: Total and partial orbi-
sion with TNF-alpha and melphalan for distal parts of the limb in tectomy for the treatment of periorbital tumors in 24 dogs and 6
soft tissue sarcoma patients, J Surg Oncol 105:563–569, 2012. cats; a retrospective study, Vet Surg 25:471–479, 1996.
238. Zachos TA, Aiken SW, DiResta GR, et al.: Interstitial fluid pres- 261. Liptak JM, Dernell WS, Rizzo SA, et al.: Reconstruction of chest
sure and blood flow in canine osteosarcoma and other tumors, Clin wall defects after rib tumor resection; a comparison of autogenous,
Orthop Relat Res 230–236, 2001. prosthetic, and composite techniques in 44 dogs, Vet Surg 37:479–
239. Powers BE, Withrow SJ, Thrall DE, et al.: Percent tumor necrosis 487, 2008.
as a predictor of treatment response in canine osteosarcoma, Cancer 262. Caceres E, Zaharia M, Valdivia S, et al.: Local control of osteo-
67:126–134, 1991. genic-sarcoma by radiation and chemotherapy, Int J Radiat Oncol
240. Withrow SJ, Liptak JM, Straw RC, et al.: Biodegradable cisplatin 10:35–39, 1984.
polymer in limb-sparing surgery for canine osteosarcoma, Ann Surg 263. Gaitanyanguas M: A Study of the response of osteogenic-sarcoma
Oncol 11:705–713, 2004. and adjacent normal-tissues to radiation, Int J Radiat Oncol 7:593–
241. Lascelles BDX, Dernell WS, Correa MT, et al.: Improved survival 595, 1981.
associated with postoperative wound infection in dogs treated with 264. Machak GN, Tkachev SI, Solovyev YN, et al.: Neoadjuvant che-
limb-salvage surgery for osteosarcoma, Ann Surg Oncol 12:1073– motherapy and local radiotherapy for high-grade osteosarcoma of
1083, 2005. the extremities, Mayo Clin Proc 78:147–155, 2003.